In addition to the care of patients with IBD, scientific research is essential.
In the study outpatient clinic, studies with the latest drugs, which are not yet available on the market, are continuously offered within the framework of international studies, which of course enormously expands and enriches the therapy options of many patients who are not treated adequately. In addition, the latest possibilities for monitoring therapies with trough levels and anti-antibody levels are of course also being tested and used.